Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer

Table 1

Prognosis-related immune-related genes in gastric cancer.

ID	HR	95% CI lowest	95% CI highest	value
INHBA	1.243952	1.045644	1.479870	0.013751
F2R	1.234062	1.044292	1.458318	0.013561
PGF	1.178581	1.00036	1.388554	0.049499
PDGFRB	1.221756	1.033238	1.444669	0.019162
FABP4	1.201410	1.045077	1.381128	0.009884
GHR	1.249665	1.079721	1.446358	0.002804
STC1	1.318622	1.117481	1.555969	0.001055
NRP1	1.377816	1.159051	1.637872	0.00028
CTLA4	0.835463	0.705530	0.989325	0.037123
SLC22A17	1.237162	1.060073	1.443834	0.006932
AGT	1.208708	1.018537	1.434385	0.029987
GCG	1.176646	1.040025	1.331215	0.009790
CARD11	1.185447	1.004931	1.398390	0.043558
RNASE2	1.236653	1.042710	1.466669	0.014667
PENK	1.148276	1.003847	1.313485	0.043806
CXCR4	1.280472	1.085135	1.510972	0.003418
AGTR1	1.149173	1.000137	1.320418	0.049775
S100A12	1.171564	1.006071	1.364281	0.041564
PROC	1.211598	1.036397	1.416415	0.016014
OGN	1.173089	1.004497	1.369978	0.043732
DKK1	1.175657	1.006877	1.372728	0.040693
RBP4	1.212545	1.036249	1.418834	0.016210
APOD	1.333790	1.127181	1.578271	0.000796

Abbreviations: HR: hazard ratio; CI: confidence interval.